These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 14975942)

  • 21. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.
    Bill JR; Mack DG; Falta MT; Maier LA; Sullivan AK; Joslin FG; Martin AK; Freed BM; Kotzin BL; Fontenot AP
    J Immunol; 2005 Nov; 175(10):7029-37. PubMed ID: 16272364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells.
    Amicosante M; Berretta F; Dweik R; Saltini C
    Immunology; 2009 Sep; 128(1 Suppl):e462-70. PubMed ID: 19191908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
    Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
    Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease.
    Palmer BE; Mack DG; Martin AK; Gillespie M; Mroz MM; Maier LA; Fontenot AP
    J Immunol; 2008 Feb; 180(4):2704-12. PubMed ID: 18250483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.
    Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA
    Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C; Richeldi L; Losi M; Amicosante M; Voorter C; van den Berg-Loonen E; Dweik RA; Wiedemann HP; Deubner DC; Tinelli C
    Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
    Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
    J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic factors modify the risk of developing beryllium disease.
    Tinkle SS; Weston A; Flint MS
    Semin Respir Crit Care Med; 2003 Apr; 24(2):169-78. PubMed ID: 16088536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells.
    Fontenot AP; Keizer TS; McCleskey M; Mack DG; Meza-Romero R; Huan J; Edwards DM; Chou YK; Vandenbark AA; Scott B; Burrows GG
    J Immunol; 2006 Sep; 177(6):3874-83. PubMed ID: 16951350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF; Lai JJ; Chou AH; Wang TF; Wu CS; Hsu PN
    Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.
    Greaves SA; Atif SM; Fontenot AP
    Front Immunol; 2020; 11():474. PubMed ID: 32256501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking genetic susceptibility and T cell activation in beryllium-induced disease.
    Falta MT; Bowerman NA; Dai S; Kappler JW; Fontenot AP
    Proc Am Thorac Soc; 2010 May; 7(2):126-9. PubMed ID: 20427584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease.
    Tinkle SS; Schwitters PW; Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):969-71. PubMed ID: 8933043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.
    Fontenot AP; Newman LS; Kotzin BL
    Clin Immunol; 2001 Jul; 100(1):4-14. PubMed ID: 11414740
    [No Abstract]   [Full Text] [Related]  

  • 35. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
    Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
    Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Airway infection in stable lung transplant patients is associated with decreased intracellular T-helper type 1 pro-inflammatory cytokines in bronchoalveolar lavage T-cell subsets.
    Hodge G; Hodge S; Reynolds PN; Holmes M
    Transpl Infect Dis; 2008 Apr; 10(2):99-105. PubMed ID: 17511818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic beryllium disease: a hypersensitivity disorder.
    Rossman MD
    Appl Occup Environ Hyg; 2001 May; 16(5):615-8. PubMed ID: 11370939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
    Gaede KI; Amicosante M; Schürmann M; Fireman E; Saltini C; Müller-Quernheim J
    J Mol Med (Berl); 2005 May; 83(5):397-405. PubMed ID: 15750822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell recognition in chronic beryllium disease.
    Amicosante M; Fontenot AP
    Clin Immunol; 2006 Nov; 121(2):134-43. PubMed ID: 16697706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.